Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy

The goal of this study was to assess how PD-L1 expression in tissue specimens of patients with main molecular subtypes of NMIBC (luminal, basal and double-negative p53-mutant) associates with relapsed-free survival in dependence on the tumor grade and prior treatment of primary bladder cancer. PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Blinova, Ekaterina, Enikeev, Dmitry, Roshchin, Dmitry, Samyshina, Elena, Deryabina, Olga, Tertychnyy, Aleksander, Blinov, Dmitry, Kogan, Evgenia, Dudina, Marina, Barakat, Haydar, Merinov, Dmitrij, Kachmazov, Aleksandr, Serebrianyi, Stanislav, Potoldykova, Natalia, Perepechin, Dmitrij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281187/
https://www.ncbi.nlm.nih.gov/pubmed/32455829
http://dx.doi.org/10.3390/cancers12051316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281187/
https://www.ncbi.nlm.nih.gov/pubmed/32455829
http://dx.doi.org/10.3390/cancers12051316

Ejemplares similares